Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Culture Zone! UK.
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
July 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 | 31 |
August 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
4 | 5 | 6 | 7 | 8 | 9 | 10 |
11 | 12 | 13 | 14 | 15 | 16 | 17 |
18 | 19 | 20 | 21 | 22 | 23 | 24 |
25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on May 19, 2025

Cinnamon Velifushi Maldives Launches Exclusive Summer Offer Featuring Complimentary Transfers and Customised Benefits
MALDIVES, May 19, 2025 /EINPresswire.com/ -- Cinnamon Velifushi Maldives has announced a limited-time summer offer designed to enhance guest experiences with a series of exclusive benefits, including complimentary return transfers, personalised perks, …

Hail Investment Forum - $14.3 Billion Await Investors
The Hail Investment Forum 2025 has officially kicked off in the Saudi city of Hail, HAIL, HAIL, SAUDI ARABIA, May 19, 2025 /EINPresswire.com/ -- The Hail Investment Forum 2025 has officially kicked off in the Saudi city of Hail, under the patronage of …

Vape and Go Launches Compliant, Refillable and Rechargeable Vapes in Response to United Kingdom’s Disposable Vape Ban
Preston, England, May 19, 2025 (GLOBE NEWSWIRE) -- Vape and Go, the UK’s premier destination for high-quality vaping products and accessories, is happy to announce the launch of its compliant, refillable, and rechargeable alternative vapes in response to …

OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …